Advertisement

Cambridge Heart Inc. (OTCBB: CAMH), which develops non-invasive diagnostic tests for heart disease, said today that a patient trial of its test to predict life-threatening heart rhythms and sudden cardiac death showed positive results.

SOURCE

Advertisement
Advertisement